JPRN-UMIN000001450
Completed
Phase 2
Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancer - Phase II trial of neoadjuvant chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancer
Faculty of Medicine, Kyoto University0 sites35 target enrollmentOctober 21, 2008
Conditionslocally advanced pancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- locally advanced pancreatic cancer
- Sponsor
- Faculty of Medicine, Kyoto University
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Watery diarrhea 2\)Severe mental disorder 3\)Active infection 4\)Severe complications, such as ileus, heart failure and renal failure 5\)Symptomatic pulmonary fibrosis or interstitial pneumonia 6\)History of radiation therapy to the chest 7\)Marked pleural or peritoneal effusion 8\)Active concomitant malignancy 9\)Treatment with phenytoin, potassium warfarin or flucytosine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II multicenter trial of neoadjuvant chemotherapy followed by radical hysterectomy and adjuvant chemotherapy by irrinotecan hydrochloride and nedaplatin for the patients with stage Ib2-IIb bulky cervical cancer (tumor diameter > 4 cm): OGSK_KCOG-G1201JPRN-UMIN000008023The Obstetrical and Gynecological Society of Kinki District Japan and the Kansai Clinical Oncology Group68
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaoral squamous cell carcinomaJPRN-C000000023Chubu research group on oral cancer30
Completed
Phase 2
Multicenter phase II trial of neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin for HER2-positive operable breast cancer: KBOG-1204 trialJPRN-UMIN000010227Kanagawa Breast Oncology Group (KBOG)40
Recruiting
Phase 2
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically resectable Non-Small- Cell Lung Cancer (NSCLC)2024-514821-45-00Medizinische Universitaet Innsbruck33
Completed
Phase 2
A Phase II study of neoadjuvant combination chemotherapy with TS-1, cisplatin and Paclitaxel (PCS) for resectable advanced gastric cancer.resectable advanced gastric cancerJPRN-UMIN000006674Kinki University Faculty of Medicine20